One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Coronavirus 229E is the earliest reported human coronavirus (hCoV-229E). Researchers used cryo-EM, glycoproteomics, and modeling to generate the atomic structure of a fully glycosylated and ...

The immune molecule TGFβ has been found to weaken ... Previous findings of high TGFβ levels in adults with severe COVID-19 made us wonder whether this cytokine could have a role.